ARTICLE | Clinical News
Busulipo regulatory update
November 4, 2013 8:00 AM UTC
Pharmalink said FDA granted Orphan Drug designation for Busulipo, a liposome formulation of the generic chemotherapeutic busulfan, as a conditioning agent for use in cancer patients prior to hematopoi...